BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Zhou K. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction. Clinical Breast Cancer 2020;20:41-50.e8. [DOI: 10.1016/j.clbc.2019.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Bourzikat O, El Abbouchi A, Ghammaz H, El Brahmi N, El Fahime E, Paris A, Daniellou R, Suzenet F, Guillaumet G, El Kazzouli S. Synthesis, Anticancer Activities and Molecular Docking Studies of a Novel Class of 2-Phenyl-5,6,7,8-tetrahydroimidazo [1,2-b]pyridazine Derivatives Bearing Sulfonamides. Molecules 2022;27:5238. [DOI: 10.3390/molecules27165238] [Reference Citation Analysis]
2 Liu D, Hofman P. Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer. Cell Oncol (Dordr) 2022. [PMID: 35543859 DOI: 10.1007/s13402-022-00677-6] [Reference Citation Analysis]
3 Pose Lapausa P, Soria Comes T, Calabria I, Maestu Maiques I. Molecular Characterization, Via Next-Generation Sequencing, of Refractory or Resistant Invasive Breast Carcinoma. Cureus. [DOI: 10.7759/cureus.19528] [Reference Citation Analysis]
4 Liu D. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers. Breast Cancer Res Treat 2020;183:95-105. [PMID: 32601968 DOI: 10.1007/s10549-020-05770-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Liu D. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer. Cell Oncol (Dordr) 2020;43:321-33. [PMID: 31933152 DOI: 10.1007/s13402-019-00492-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]